BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23652051)

  • 1. Osteopontin knockdown suppresses non-small cell lung cancer cell invasion and metastasis.
    Sun BS; You J; Li Y; Zhang ZF; Wang CL
    Chin Med J (Engl); 2013; 126(9):1683-8. PubMed ID: 23652051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plumbagin reduces osteopontin-induced invasion through inhibiting the Rho-associated kinase signaling pathway in A549 cells and suppresses osteopontin-induced lung metastasis in BalB/c mice.
    Kang CG; Im E; Lee HJ; Lee EO
    Bioorg Med Chem Lett; 2017 May; 27(9):1914-1918. PubMed ID: 28359791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma.
    Sun BS; Dong QZ; Ye QH; Sun HJ; Jia HL; Zhu XQ; Liu DY; Chen J; Xue Q; Zhou HJ; Ren N; Qin LX
    Hepatology; 2008 Dec; 48(6):1834-42. PubMed ID: 18972404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells.
    Mi Z; Guo H; Wai PY; Gao C; Kuo PC
    Carcinogenesis; 2006 Jun; 27(6):1134-45. PubMed ID: 16474180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasis.
    Wai PY; Mi Z; Guo H; Sarraf-Yazdi S; Gao C; Wei J; Marroquin CE; Clary B; Kuo PC
    Carcinogenesis; 2005 Apr; 26(4):741-51. PubMed ID: 15661802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A short-hairpin RNA targeting osteopontin downregulates MMP-2 and MMP-9 expressions in prostate cancer PC-3 cells.
    Liu H; Chen A; Guo F; Yuan L
    Cancer Lett; 2010 Sep; 295(1):27-37. PubMed ID: 20207476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of osteopontin inhibits metastasis of hepatocellular carcinoma cells via a mechanism involving MMP-2 and uPA.
    Chen RX; Xia YH; Xue TC; Zhang H; Ye SL
    Oncol Rep; 2011 Mar; 25(3):803-8. PubMed ID: 21174062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thirty-kilodalton Tat-interacting protein suppresses tumor metastasis by inhibition of osteopontin transcription in human hepatocellular carcinoma.
    Zhao J; Lu B; Xu H; Tong X; Wu G; Zhang X; Liang A; Cong W; Dai J; Wang H; Wu M; Guo Y
    Hepatology; 2008 Jul; 48(1):265-75. PubMed ID: 18537194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rho-associated kinase signaling is required for osteopontin-induced cell invasion through inactivating cofilin in human non-small cell lung cancer cell lines.
    Kang CG; Han HJ; Lee HJ; Kim SH; Lee EO
    Bioorg Med Chem Lett; 2015 May; 25(9):1956-60. PubMed ID: 25817589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
    Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteopontin promotes the progression of gastric cancer through the NF-κB pathway regulated by the MAPK and PI3K.
    Liu J; Liu Q; Wan Y; Zhao Z; Yu H; Luo H; Tang Z
    Int J Oncol; 2014 Jul; 45(1):282-90. PubMed ID: 24756245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lentiviral-mediated siRNA targeted against osteopontin suppresses the growth and metastasis of gastric cancer cells.
    Wang ZM; Cui YH; Li W; Chen SY; Liu TS
    Oncol Rep; 2011 Apr; 25(4):997-1003. PubMed ID: 21286666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopontin: it's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression.
    Das R; Philip S; Mahabeleshwar GH; Bulbule A; Kundu GC
    IUBMB Life; 2005 Jun; 57(6):441-7. PubMed ID: 16012053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteopontin promotes hepatocellular carcinoma invasion by up-regulating MMP-2 and uPA expression.
    Chen RX; Xia YH; Xue TC; Ye SL
    Mol Biol Rep; 2011 Aug; 38(6):3671-7. PubMed ID: 21104439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of caspase-8 in non-small cell lung cancer and its role in invasion and metastasis of lung cancer A549 cells].
    Du N; Sun XF; Hu LJ; Sun X; Li XJ; Zhao Y; Ren H
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Jun; 28(6):572-5. PubMed ID: 22691345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human macrophages promote the motility and invasiveness of osteopontin-knockdown tumor cells.
    Cheng J; Huo DH; Kuang DM; Yang J; Zheng L; Zhuang SM
    Cancer Res; 2007 Jun; 67(11):5141-7. PubMed ID: 17545592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbon-ion beam irradiation effectively suppresses migration and invasion of human non-small-cell lung cancer cells.
    Akino Y; Teshima T; Kihara A; Kodera-Suzumoto Y; Inaoka M; Higashiyama S; Furusawa Y; Matsuura N
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):475-81. PubMed ID: 19735871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High NUAK1 expression correlates with poor prognosis and involved in NSCLC cells migration and invasion.
    Chen P; Li K; Liang Y; Li L; Zhu X
    Exp Lung Res; 2013 Feb; 39(1):9-17. PubMed ID: 23215946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of brefelamide as a novel inhibitor of osteopontin that suppresses invasion of A549 lung cancer cells.
    Zhang J; Yamada O; Kida S; Matsushita Y; Murase S; Hattori T; Kubohara Y; Kikuchi H; Oshima Y
    Oncol Rep; 2016 Oct; 36(4):2357-64. PubMed ID: 27498705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-associated macrophages provide a suitable microenvironment for non-small lung cancer invasion and progression.
    Wang R; Zhang J; Chen S; Lu M; Luo X; Yao S; Liu S; Qin Y; Chen H
    Lung Cancer; 2011 Nov; 74(2):188-96. PubMed ID: 21601305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.